On the upside
Biodel (Nasdaq: BIOD) will submit a new drug application to the Food and Drug Adminstration for its diabetes treatment VIAject.
Analysts upgraded CB Richard Ellis Group (NYSE: CBG) after the real estate services firm changed its credit agreements.
Although Jabil Circuit (NYSE: JBL) widened second quarter losses, the results topped analyst estimates.
An unexpected gain in new home sales last month lifted shares of Beazer Homes (NYSE: BZH) and Hovnanian Enterprises (NYSE: HOV).
On the downside
DryShips (Nasdaq: DRYS) blamed a goodwill impairment charge along with contract termination fees for swinging to a loss for the fourth quarter.
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks climbed 7 points to 424.